These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6692041)

  • 1. Leukemic cell differentiation in vivo and in vitro: arrest of proliferation parallels the differentiation induced by the antileukemic drug Harringtonine.
    Boyd AW; Sullivan JR
    Blood; 1984 Feb; 63(2):384-92. PubMed ID: 6692041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antileukemic effect of low-dose harringtonine.
    Chen SS; Wang P; Fu JY; Chen LL; Zhao FS; Shan FX
    Chin Med J (Engl); 1989 Jun; 102(6):416-9. PubMed ID: 2512060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-dose Harringtonine induces complete remission in patients with acute promyelocytic leukemia.
    Ye JS; Wang XH; Feng GH; Liang GR; Liu ZP
    Leukemia; 1988 Jul; 2(7):427-9. PubMed ID: 3164799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study on the induction of differentiation of human leukemic cells by harringtonine combined with cytarabine.
    Huang CL; Deng ML; Guo RJ; Wu MT; Liu FZ; Liang YM; Qiao QD
    Leukemia; 1988 Aug; 2(8):518-22. PubMed ID: 3412024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curative effect of harringtonine semisynthetic harringtonine and HOAP on nonlymphocytic leukemias. Analysis of 304 cases.
    Zhang ZY; Hou CH; Zhu YF; You XY; Li JL; Fu Z
    Chin Med J (Engl); 1987 Jul; 100(7):565-8. PubMed ID: 3123163
    [No Abstract]   [Full Text] [Related]  

  • 6. [Growth inhibition of human myeloid leukemia cells in vitro by harringtonine].
    Piao YF; Okabe T; Zhang LJ
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):281-5. PubMed ID: 2301953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harringtonine in acute leukemias. Clinical analysis of 31 cases.
    Chin Med J (Engl); 1977 Sep; 3(5):319-24. PubMed ID: 411635
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of harringtonine on human leukemia cell differentiation.
    Kuliczkowski K
    Arch Immunol Ther Exp (Warsz); 1989; 37(1-2):69-76. PubMed ID: 2619511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonistic interactions of hexamethylene bisacetamide in combination with 1-beta-D-arabinofuranosylcytosine, adriamycin and harringtonine on the growth and differentiation of HL-60 cells in vitro.
    Kong XB; Fanucchi MP; Chou TC
    Leuk Res; 1988; 12(10):853-9. PubMed ID: 3199844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro antitumor activity of homoharringtonine and harringtonine against clonogenic human tumor cells.
    Jiang TL; Liu RH; Salmon SE
    Invest New Drugs; 1983; 1(1):21-5. PubMed ID: 6678854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of the therapeutic effect of semisynthetic harringtonine in treating 55 cases of nonlymphocytic leukemia (author's transl)].
    Zhang ZY
    Zhonghua Nei Ke Za Zhi; 1981 Nov; 20(11):667-9. PubMed ID: 7341094
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ultrastructural studies on differentiation of human leukemic cell induced by retinoic acid and harringtonine].
    Si JY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Oct; 10(5):376-8. PubMed ID: 2978260
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intrathecal injection of harringtonine and homoharringtonine in treating central nervous system leukemia--clinical analysis of 26 cases (author's transl)].
    Hou CH; Zhang ZY
    Zhonghua Yi Xue Za Zhi; 1981 Sep; 61(9):530-2. PubMed ID: 6804061
    [No Abstract]   [Full Text] [Related]  

  • 14. Uptake, initial effects, and chemotherapeutic efficacy of harringtonine in murine leukemic cells sensitive and resistant to vincristine and other chemotherapeutic agents.
    Chou TC; Schmid FA; Feinberg A; Philips FS; Han J
    Cancer Res; 1983 Jul; 43(7):3074-9. PubMed ID: 6189591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of homoharringtonine on proliferation and differentiation of human leukemic cells in vitro.
    Zhou JY; Chen DL; Shen ZS; Koeffler HP
    Cancer Res; 1990 Apr; 50(7):2031-5. PubMed ID: 2317793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antitumor activities and mechanisms of action of harringtonine and homoharringtonine].
    Kato T; Takamoto S; Mizutani M; Hato M; Ota K
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2393-9. PubMed ID: 6497398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of harringtonine cytotoxicity by calcium antagonist diltiazem and biscoclaurine alkaloid cepharanthine in adriamycin-resistant P388 murine leukemia and K562 human leukemia cells.
    Yamamoto S; Hui PZ; Fukuda Y; Tatsumi K; Mino M
    Biochem Int; 1989 Jun; 18(6):1077-83. PubMed ID: 2751676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A preliminary therapeutic analysis of 82 cases of chronic granulocytic leukemia treated with harringtonine].
    Zhang ZY; Hou CH; Zhu YF
    Zhonghua Nei Ke Za Zhi; 1986 Mar; 25(3):156-7, 190. PubMed ID: 3461929
    [No Abstract]   [Full Text] [Related]  

  • 19. Long survival in an elderly patient with acute myeloid leukaemia after treatment with harringtonine.
    Sullivan J; Leyden M
    Med J Aust; 1985 Jun; 142(13):693-4. PubMed ID: 3859742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of chromosomal aberrations, cytotoxicity, and morphological transformation in mammalian cells by the antiparasitic drug flubendazole and the antineoplastic drug harringtonine.
    Huang N; Cerepnalkoski L; Nwankwo JO; Dews M; Landolph JR
    Fundam Appl Toxicol; 1994 Feb; 22(2):304-13. PubMed ID: 8005380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.